Edwards Lifesciences rises after co raises 2025 sales forecast
View all comments(0)
Shares of medical device maker Edwards Lifesciences EW.N rise 4.3% to $73.50 premarket
Company late on Wednesday raised its 2025 sales forecast to a range of $5.7 billion to $6.1 billion, from between $5.6 billion and $6 billion earlier
Edwards expects a tariff impact of 5 cents per share for 2025, with a larger hit expected in 2026
Company posted Q1 adj. profit of 64 cents per share, beating analysts' estimates of 60 cents per share, according to data compiled by LSEG
Co also reaffirmed its 2025 adjusted profit of $2.40 to $2.50 per share
As of last close, EW has fallen 4.8% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.